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doi:10.1016/j.jtcvs.2005.12.027trial fibrillation surgery has become an area of major interest for cardiac
surgeons. This is not surprising, because there is increasing information
showing that surgery should play a larger role in the therapeutic armamen-
arium of this enigmatic syndrome, or primary disease. Starting in 1980, Williams
nd colleagues1 and Defauw and colleagues2 proposed 2 surgical  techniques, isolation
f the left atrium and the corridor procedure, respectively, to obtain rate control of this
ifficult and complex pathology.
In 1991, Cox and colleagues3,4 described the maze 1 operation  and later  the maze
and maze 3 operations. These techniques were the first attempts to surgically
chieve a rhythm-control therapy for atrial fibrillation, and the maze 3 became the
old standard for surgical treatment of atrial fibrillation. Because the maze 3 is a
omplex operation, requiring a long ischemic time and having a major potential for
leeding, it never became a widespread technique.
With a completely different approach  based on information from Hannover,5 in
998 our group was the first to describe the surgical treatment of permanent atrial
brillation using bilateral  isolation of the pulmonary veins 6 in patients with mitral
alve disease, by using endocardial radiofrequency catheter ablation. The concept
ehind this approach is to avoid macroreentry, which inside the left atrium is mostly
ccurring around the ostia of the pulmonary veins, where refractory periods are
uch shorter  than in the cavity of the left atrium.7 Cox and colleagues8 state that
atrial fibrillation . . . could come from the PV but they were not mapped.”
Concomitantly and independently, Haissaguerre  and colleagues9 described ec-
opic foci within the pulmonary veins as the origin of lone atrial fibrillation in some
atients with paroxysmal lone atrial fibrillation, and reported very high early success
ates.
The suboptimal results we reported initially were obtained in unselected patients
ho underwent operation with unipolar dry radiofrequency. Failure may have been
aused by the difficulties in achieving consistent transmurality or the multiplicity of
echanisms leading to atrial fibrillation, well beyond the role of the pulmonary
eins.
In an attempt to improve results, and always using ablation limited to the left
trium, different approache s10 and additional  lines11 were proposed by several
roups.
Different heating and cooling energies became available  in the surgical  arma-
entarium as alternatives  to the cut-and-sew method.12,13 So far, only a few of those
nergies have shown to be consistently transmural.
By analyzing the surgical results of patients who undergo operation with the use
f such tools, it is clear that the results are now consistent and the success rate needs
o be improved, mainly in patients with lone atrial fibrillation. In many patients the
echanisms for atrial fibrillation are not limited to the left atrium but are also
ocated in the right atrium. This is not surprising and is in accordance with past
nowledge. Indeed, for some time our electrophysiologist colleagues have been
uring lone atrial fibrillation using right atrial ablation with a 1-year success rate in
he range of 15%.14,15 The maze operation achieves the higher reported success
ates16 and is a biatrial  approach.  These facts are  in line with Barnett and Ad’
rticle17 in this issue of The Journal, and reinforce the concept that biatrial  surgery
eads to a higher success rate in the treatment of atrial fibrillation.
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LIf surgery is to stay in the mainstream of the armamen-
arium for the treatment of atrial fibrillation we have to
ecognize that our current knowledge is not sufficient. The
hallenge now is how to increase our knowledge and obtain
he best sustained results after surgery.
Atrial fibrillation is a multifactor condition and presents
nder different forms. It is generally accepted as a syndrome
f increasing severity. Atrial fibrillation usually starts as a
aroxysmal condition and evolves into a permanent condi-
ion. It is much easier to cure in the early stages. The results
f nonpharmacologic treatment of atrial fibrillation are far
uperior when performed in patients with persistent or par-
xysmal atrial fibrillation than in patients with permanent
trial fibrillation. This is true in patients with lone atrial
brillation or mitral valve disease. In those with paroxysmal
trial fibrillation, even without ablation a substantial num-
er of patients will recover sinus rhythm by repairing the
itral valve and unloading the atrium.
Barnett and Ad’s article  17 reviews a large  number of
rticles discussing more than 6000 patients, but because
ost of the data were not accessed or analyzed together, its
onclusions should be cautiously assessed. It should be
oted that although the title of this literature review includes
ablation,” some of the articles discuss standard surgery,
ost frequently the results of the maze operation.
The percutaneous approaches have evolved from the
oncepts of ectopic foci within the pulmonary veins to
ilateral isolation of the pulmonary veins, as described by
appone  and colleagues18 and later  by Macle and col-
eagues.19 Comparing the results of surgery with the results
f percutaneous ablation is not appropriate because patients
ndergoing surgery usually have a failed percutaneous ab-
ation. The series from Prasad  et al.,16 performed in an era
n which interventions were not available, show that surgi-
al treatment is highly efficient. It should be emphasized
hat treating this arrhythmia in patients with atrial fibrilla-
ion and concomitant heart pathology in addition to the
itral valve is more difficult than in those patients with lone
trial fibrillation.
Surgical approaches need to be simplified and safe. Five
ears ago our group reported the initial experience of bilat-
ral isolation of the pulmonary veins without cardiopulmo-
ary bypass for the treatment of lone atrial fibrillation using
edian sternotomy. 20 Recently, several groups have reported
ini-invasive approaches .21,22 Surgeons have the responsibil-
ty to document that when these procedures are performed
horacoscopically, the results are similar and long-lasting.
One of the most important benefits we can offer to many
atients is a decrease in the incidence of thromboembolic
vents associated with atrial fibrillation. By analyzing clin-
cal and echocardiographic risk factors it is possible to
dentify the patients who are  at high risk for stroke.23
ecause the left atrium appendage is the origin of these e
50 The Journal of Thoracic and Cardiovascular Surgery ● Mayhrombi, we have the unique opportunity of eliminating the
ppendage, and because we use no intracardiac foreign
odies, this is likely the most effective method to decrease
he incidence of thromboembolism.
Another concept to clarify is the definition of success.
ur aim in atrial fibrillation treatment should be to achieve
inus rhythm and to avoid the major drawbacks of atrial
brillation, that is, thromboembolic events and the need for
reatment with antiarrhythmics. All of those medications
ave proarrhythmic effects that cause a significant number
f sudden late deaths.24 When reporting  sinus rhythm we
hould document normal sinus rhythm, which is not the
ame as free of atrial fibrillation, as too commonly reported.
ow sinus rhythm is defined cannot be based on symptoms
r an occasional electrocardiogram. In those patients with
aroxysmal atrial fibrillation, sinus rhythm, definition requires
olter monitoring. In those patients with permanent atrial
brillation it is essential to document that they do not have
aroxysmal atrial fibrillation, thus requiring more than a
outine electrocardiogram to detect their basic rhythm. In
arnett and Ad’s review, 17 the criteria  for rhythm success is
reedom from atrial fibrillation. In addition, a substantial
umber of articles are not detailing the methods used for
efining the rhythm, thus becoming less informative and
ometimes useless. Eventually we can postulate that the
eason  Barnett and Ad’s study 17 did not show better survival
s that the only rhythm that might lead to an improved
urvival is sinus rhythm and that a substantial number of
atients without atrial fibrillation are not in sinus rhythm.
eaders are rarely informed on additional medications that
atients require during follow-up, which seems to have a
irect impact on survival.
At the moment several crucial issues remain to be an-
wered.
1. Is there the need to routinely create lines in the right
and left atria?
2. Inside the left atrium the pulmonary veins are a major
component for the origin or perpetuation of atrial
fibrillation. Are additional lines necessary, and, if so,
where should they be created?
3. What is the role of the left atrial appendage in atrial
fibrillation? Does it have any proarrhythmic poten-
tial?
4. What is the role of the autonomic nervous system in
the origin or perpetuation of atrial fibrillation?
These are some of the issues that require a definite
nswer. The coming years will be rich in research on atrial
brillation surgery. The ultimate goal is to develop a proce-
ure that will be performed on the beating heart using ports and
lways eliminating the left atrial appendage. When that tech-
ology is available it will be a challenge to decide, with our
lectrophysiologist colleagues, which is the easiest and saf-
st way to create those ablation lines.
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LIn the meantime it is crucial that surgeons and electro-
hysiologists work in close cooperation to provide answers
o the questions described.
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